SEMINARS IN NEUROLOGY is a leading journal in the field of neurology, published by THIEME MEDICAL PUBL INC. With its ISSN 0271-8235 and E-ISSN 1098-9021, this esteemed journal has been a vital resource for the neurology community since its inception in 1984. Covering critical advancements and contemporary issues in both neurology and clinical neurology, it holds a reputable position in the Q2 category for both disciplines as of 2023. The journal ranks #164 out of 400 in clinical neurology, indicating its significant contribution to the field, and is indexed in Scopus for robust academic exposure. SEMINARS IN NEUROLOGY offers a platform for authors to disseminate groundbreaking research and reviews, ultimately enhancing knowledge and practice in neurological sciences. With unrestricted access options, it seeks to engage researchers, practitioners, and students, fostering a comprehensive understanding of the complexities of neurological disorders and therapies.

The International Journal of Noncommunicable Diseases, published by Wolters Kluwer Medknow Publications, is a leading open-access journal dedicated to advancing research in the field of noncommunicable diseases (NCDs). Since its inception in 2016, the journal has provided a robust platform for the dissemination of high-quality studies, reviews, and case reports that address the growing burden of NCDs globally. With a commitment to enhancing knowledge and understanding, the journal aims to navigate the complexities of prevention, diagnosis, management, and policy implications related to diseases such as diabetes, cardiovascular conditions, and cancers. The journal features an inclusive editorial board made up of renowned experts in the field, ensuring rigorous peer review and maintaining a high standard of scholarly excellence. As an open-access journal, it promotes widespread availability of its content, fostering collaboration and innovation among researchers, healthcare professionals, and students alike. Engage with the latest research and contribute to the growing body of knowledge in this critical area of public health by exploring the International Journal of Noncommunicable Diseases.

METABOLIC BRAIN DISEASE, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to advancing our understanding of the metabolic processes impacting brain health and disease. Established in 1986 and set to continue until 2024, this journal encompasses a wide range of interdisciplinary research that intersects the fields of Biochemistry, Cellular and Molecular Neuroscience, and Neurology, as evidenced by its notable quartile placements in Q2 and Q3 for 2023. With an ISSN of 0885-7490 and an E-ISSN of 1573-7365, it serves as a vital resource for researchers and practitioners aiming to deepen their insights into cerebral metabolic disorders and their implications. Although currently not an Open Access option, its rigorous peer-review process ensures that high-quality, impactful research reaches its audience. Showcasing a significant rank within the top percentile of its categories, METABOLIC BRAIN DISEASE is instrumental in shaping the future of neurological research and clinical applications.

NEUROLOGIC CLINICS, published by W B SAUNDERS CO-ELSEVIER INC, stands as a leading journal in the field of clinical neurology, boasting an impressive impact factor that reflects its significant contributions to neurological research and clinical practice. With an ISSN of 0733-8619 and E-ISSN of 1557-9875, this journal provides a critical platform for the dissemination of innovative research, case studies, and reviews focusing on various aspects of neurology, from diagnosis to treatment interventions. As part of its commitment to advancing the understanding of neurological disorders, NEUROLOGIC CLINICS is categorized in the Q2 quartile for Neurology (clinical) in 2023, indicating its robust standing within the academic community. It is recognized for its rigorous peer-review process and is indexed in Scopus, ranking #147 out of 400 in its field with a notable 63rd percentile. The journal, which dates back to 1983 and continues to publish vital findings up to 2024, is an invaluable resource for researchers, healthcare professionals, and students dedicated to enhancing their knowledge and clinical skills in neurology. Subscribe now to stay abreast of current advancements and expand your expertise in this dynamic field.

Zeitschrift für Neuropsychologie, published by HOGREFE AG in Switzerland, stands as a vital resource for scholars and practitioners in the fields of neuropsychology, cognitive neuroscience, and psychiatry. With an ISSN of 1016-264X and E-ISSN 1664-2902, this journal aims to disseminate high-quality research that enhances understanding of cognitive processes and their implications for mental health. While currently classified in the fourth quartile across relevant categories, including Cognitive Neuroscience and Neuropsychology, it offers valuable insights that contribute to the emerging discourse in these areas. By publishing both empirical studies and theoretical papers, it encourages interdisciplinary dialogues among researchers and clinicians. Although the journal is not Open Access, its role in advancing neuropsychological research is significant, fostering academic linkages from its base in Bern, Switzerland. By continually focusing on the latest advancements and fostering innovative approaches within the field, Zeitschrift für Neuropsychologie remains a crucial platform for those committed to exploring the complexities of the human mind.

The Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.

JAMA Neurology is a leading peer-reviewed journal published by the American Medical Association, focused on advancing the understanding and treatment of neurological disorders. With an impressive impact factor and ranked in the 99th percentile among clinical neurology journals, this publication is recognized as Q1 in its category for 2023, highlighting its significance in the field. Since its inception, the journal has provided a platform for high-quality research, clinical trials, and reviews that inform both clinicians and researchers. Operating from its headquarters in Chicago, Illinois, JAMA Neurology offers rich insights into the latest advancements in neurology, featuring articles that span a wide range of topics including neurodegenerative diseases, stroke, epilepsy, and neurocritical care. Researchers and professionals are encouraged to access the journal’s content freely, as it employs open access options to promote the dissemination of critical knowledge. As a critical resource in the field of neurology, JAMA Neurology is essential for anyone involved in this dynamic and rapidly evolving specialty.

Neurology Asia is a prestigious peer-reviewed journal dedicated to advancing the field of neurology in the Asia-Pacific region. Published by the ASEAN NEUROLOGICAL ASSOCIATION, this journal serves as a vital platform for sharing innovative research and clinical practices among neurologists and neuroscientists. With an ISSN of 1823-6138, it encompasses a broad range of topics within the realm of neurology and clinical neurology, allowing for an expansive dialogue on neurological disorders, treatments, and advancements in medical science. Although currently positioned in the Q4 quartile of both neurology and clinical neurology categories, it is committed to enhancing its reputation and impact within the academic community. While the journal is not an open-access publication, it strives to provide authors a respectable outlet for disseminating critical research findings. The journal’s address, located at the UNIV MALAYA MEDICAL CENTRE in Kuala Lumpur, Malaysia, reflects its commitment to fostering regional advancements in neurological research. By engaging with Neurology Asia, researchers, professionals, and students will contribute to shaping the future of neurology across Asia.

Canadian Journal of Neurological Sciences, published by Cambridge University Press, stands as a reputable source of knowledge in the field of neurology, dedicated to advancing research and clinical practice. With an ISSN of 0317-1671 and an E-ISSN of 2057-0155, this journal has been a cornerstone for the exchange of ideas since its inception in 1974 and will continue to cater to the academic community until 2024. Recognized in the top quartile (Q2) in various categories including Medicine (miscellaneous) and Neurology (clinical), its articles engage a broad audience, ranging from established researchers to students seeking to deepen their understanding of neurological sciences. Although the journal is not an open-access publication, it provides vital insights and research findings that contribute significantly to its fields. With a Scopus rank of #183 in clinical neurology and a percentile ranking that reflects its commendable standing, the Canadian Journal of Neurological Sciences is indispensable for those committed to the exploration and treatment of neurological disorders.

The Journal of Epidemiology and Global Health (ISSN: 2210-6006; E-ISSN: 2210-6014), published by SpringerNature, stands as a premier open-access platform in the field of epidemiology, dedicated to advancing our understanding of global health challenges since 2011. Based in Switzerland, this journal is recognized for its significant contributions to the discipline, achieving an impressive Q1 ranking in Epidemiology and positioning itself at the 88th percentile within the Scopus Medicine - Epidemiology category. With a goal to disseminate innovative research and foster dialogue among scholars, public health professionals, and students, the journal provides a rich repository of empirical studies, reviews, and theoretical contributions that address pressing epidemiological issues. Its commitment to open access ensures that vital research is freely available to the global community, thereby amplifying its impact and relevance. Researchers seeking to publish and access high-quality, peer-reviewed articles will find the Journal of Epidemiology and Global Health an invaluable resource in navigating the ever-evolving landscape of public health.